Behavioral Neuroscience · 2006 · 23 citations · 15 references
MedicinePharmacologyPharmacotherapyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyDrug DependenceFlumazenil TherapyBenzodiazepine Receptor AgonistsBenzodiazepine TreatmentDependence PotentialDiscriminative StimulusOperant BehaviorPharmacodynamics Of Flumazenil
The acute and chronic effects of ramelteon, an MT1/MT2 receptor agonist, were evaluated in rhesus monkeys (Macaca mulatta) to assess discriminative stimulus effects in comparison with traditional benzodiazepine receptor agonists and to assess physical dependence potential. Discriminative effects of ramelteon were compared with midazolam in untreated monkeys and in diazepam-dependent monkeys that discriminated flumazenil. Dependence potential of ramelteon after daily 1-year administration (and intermittent discontinuation) was evaluated with standard operant procedures. Ramelteon did not produce benzodiazepine-like discriminative stimulus effects at doses up to 10 mg/kg. Long-term treatment or its discontinuation had no significant effect on spontaneous behavior, operant behavior, body weight, motor activity, or posture. These findings suggest that ramelteon is not likely to have benzodiazepine-like abuse or dependence liability.
15
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Koki Kato, Keisuke Hirai, Keiji Nishiyama et al. · Neuropharmacology · 2004 · 537 citations
The Sleep-Promoting Action of Ramelteon (TAK-375) in Freely Moving Cats
Masaomi Miyamoto, Hisao Nishikawa, Yayoi Doken et al. · SLEEP · 2004 · 75 citations
Medicine, Neuroscience, Pharmacology +17
Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys
Nobuhito Yukuhiro, Hiroyuki Kimura, Hisao Nishikawa et al. · Brain Research · 2004 · 66 citations
A. Richard Green, David Nutt, Philip J. Cowen · Psychopharmacology · 1982 · 39 citations